Simplex Trading, LLC Bei Gene, Ltd. Transaction History

Simplex Trading, LLC

$3.28 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$141.8 - $181.47 $487,650 - $624,075	3,439 New	3,439 $537,000
Q3 2023 Nov 01, 2023	BUY	$179.87 - $225.13 $133,283 - $166,821	741 Added 96.48%	1,509 $271,000
Q2 2023 Aug 04, 2023	BUY	$178.3 - $266.78 $136,934 - $204,887	768 New	768 $136,000
Q4 2022 Feb 02, 2023	BUY	$125.51 - $229.3 $443,050 - $809,429	3,530 New	3,530 $776,000
Q2 2022 Aug 03, 2022	SELL	$121.11 - $216.05 $3,875 - $6,913	-32 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$146.52 - $269.56 $155,457 - $286,003	-1,061 Reduced 97.07%	32 $6,000
Q4 2021 Feb 23, 2022	BUY	$248.56 - $389.34 $145,407 - $227,763	585 Added 115.16%	1,093 $296,000
Q2 2021 Aug 12, 2021	BUY	$292.75 - $367.01 $52,109 - $65,327	178 Added 53.94%	508 $174,000
Q1 2021 Apr 26, 2021	BUY	$260.64 - $382.12 $86,011 - $126,099	330 New	330 $114,000
Q4 2020 Feb 02, 2021	SELL	$221.31 - $316.61 $987,927 - $1.41 Million	-4,464 Closed	0 $0
Q3 2020 Oct 14, 2020	BUY	$189.18 - $286.44 $637,914 - $965,875	3,372 Added 308.79%	4,464 $1.28 Million
Q2 2020 Jul 13, 2020	BUY	$123.9 - $195.41 $93,420 - $147,339	754 Added 223.08%	1,092 $205,000
Q1 2020 Apr 29, 2020	SELL	$121.84 - $173.19 $454,706 - $646,345	-3,732 Reduced 91.7%	338 $41,000
Q4 2019 Feb 05, 2020	BUY	$115.78 - $208.34 $340,045 - $611,894	2,937 Added 259.22%	4,070 $674,000
Q3 2019 Oct 15, 2019	BUY	$120.61 - $148.29 $136,651 - $168,012	1,133 New	1,133 $138,000
Q1 2019 Apr 18, 2019	SELL	$122.82 - $151.83 $194,915 - $240,954	-1,587 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$107.01 - $175.15 $169,824 - $277,963	1,587 New	1,587 $222,000
Q3 2018 Oct 23, 2018	SELL	$152.62 - $189.66 $61,200 - $76,053	-401 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$152.5 - $216.77 $52,612 - $74,785	-345 Reduced 46.25%	401 $61,000
Q1 2018 Apr 26, 2018	SELL	$97.41 - $177.22 $74,323 - $135,218	-763 Reduced 50.56%	746 $125,000
Q4 2017 Jan 10, 2018	BUY	$79.6 - $114.73 $21,253 - $30,632	267 Added 21.5%	1,509 $147,000
Q3 2017 Oct 25, 2017	BUY	$66.19 - $103.46 $82,207 - $128,497	1,242	1,242 $128,000

Others Institutions Holding BGNE

# of Institutions

254

Shares Held

45.1M

Call Options Held

131K

Put Options Held

95.6K

Baker Bros. Advisors LP New York, NY

9.53M
Shares

$2.16 Billion
19.52% of portfolio
Capital International Investors Los Angeles, CA

6.11M
Shares

$1.39 Billion
0.22% of portfolio
Primecap Management CO Pasadena, CA

5.1M
Shares

$1.16 Billion
0.74% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

3.8M
Shares

$862 Million
26.88% of portfolio
Baillie Gifford & CO

3.67M
Shares

$832 Million
0.54% of portfolio

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $23.5B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account